Reaction
Herpes Simplex Hepatitis reporting signals
As of the last recalculation, Herpes Simplex Hepatitis appears in 233 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 261.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 30 | 261.4 | 262.1 |
| Mycophenilic Acid | 22 | 104.6 | 104.7 |
| Valganciclovir Hydrochloride Powder, | 10 | 76.5 | 76.5 |
| Cefazolin | 7 | 70.6 | 70.7 |
| Mycophenolic Acid | 22 | 67.7 | 67.7 |
| Everolimus Tablets | 12 | 67.3 | 67.4 |